Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid

Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced

Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 961 · see citing works

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 956 · see citing works

Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing

Trounce, I., Byrne, E., & Marzuki, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92143-0 · Cited by 730 · see citing works

Evidence for Degenerative and Regenerative Changes in Neostriatal Spiny Neurons in Huntington's Disease

Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612 · see citing works

3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin

Ludolph, A. C., He, F., Spencer, P. S., Hammerstad, J. P., & Sabri, M. I. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032212 · Cited by 484 · see citing works

3-Nitropropionate, the toxic substance of Indigofera , is a suicide inactivator of succinate dehydrogenase

Alston, T. A., Mela, L., & Bright, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3767 · Cited by 380 · see citing works

Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry

Ferrante, R., Kowall, N., & Richardson, E. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-12-03877.1991 · Cited by 306 · see citing works

Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage

Hamilton, B. F., & Gould, D. H. (1987) · Acta Neuropathologica · doi:10.1007/bf00691103 · Cited by 231 · see citing works

1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism

Storey, E., Hyman, B. T., Jenkins, B. G., Brouillet, E., Miller, J. M., Rosen, B. R., & Beal, M. F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10080.x · Cited by 164 · see citing works

Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina.

Zeevalk, G. D., & Nicklas, W. J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13234-5 · Cited by 164 · see citing works

BASAL GANGLIA DEGENERATION, MYELIN ALTERATIONS, AND ENZYME INHIBITION INDUCED IN MICE BY THE PLANT TOXIN 3‐NITROPROPANOIC ACID

Gould, D. H., & Gustine, D. L. (1982) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1982.tb00306.x · Cited by 119 · see citing works

Aminooxyacetic Acid Results in Excitotoxin Lesions by a Novel Indirect Mechanism

Beal, M. F., Swartz, K. J., Hyman, B. T., Storey, E., Finn, S. F., & Koroshetz, W. J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08258.x · Cited by 118 · see citing works

The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment

Irwin, I., Finnegan, K. T., DeLanney, L. E., Monte, D. A. D., & Langston, J. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)90473-m · Cited by 95 · see citing works

Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels

Riepe, M. W., Hori, N., Ludolph, A. C., Carpenter, D. O., Spencer, P. S., & Allen, C. N. (1992) · Brain Research · doi:10.1016/0006-8993(92)91371-k · Cited by 90 · see citing works

Age-related Decrease in Respiratory Muscle Mitochondrial Function in Rats

Torii, K., Sugiyama, S., Takagi, K., Satake, T., & Ozawa, T. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/6.1.88 · Cited by 82 · see citing works

Effects of aging on quinolinic acid lesions in rat striatum

Finn, S. F., Hyman, B. T., Storey, E., Miller, J. M., & Beal, M. F. (1991) · Brain Research · doi:10.1016/0006-8993(91)90631-5 · Cited by 21 · see citing works

Oxidative Stress, Glutamate, and Neurodegenerative Disorders

Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762 · see citing works

Aging, energy, and oxidative stress in neurodegenerative diseases

Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434 · see citing works

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

Blum, D. L., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A., Sadoul, R., & Verna, J. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246 · see citing works

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026 · see citing works

Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain

Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757 · see citing works

The Role of Excitotoxicity in Neurodegenerative Disease

Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723 · see citing works

Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

Beal, M. F., Hyman, B. T., & Koroshetz, W. J. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90117-5 · Cited by 574 · see citing works

Oxidative stress in Huntington’s disease

Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508 · see citing works

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.

Brouillet, E., Hantraye, P., Ferrante, R. J., Dolan, R., Leroy‐Willig, A., Kowall, N. W., & Beal, M. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7105 · Cited by 485 · see citing works

Mechanisms of neurodegeneration in Huntington’s disease

Gil‐Mohapel, J., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 480 · see citing works

Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease

Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R. F., & Beal, M. F. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00156.1998 · Cited by 431 · see citing works

Replicating Huntington's disease phenotype in experimental animals

Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413 · see citing works

Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington's Disease Mutation

Lione, L. A., Carter, R. J., Hunt, M. J., Bates, G. P., Morton, A. J., & Dunnett, S. B. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10428.1999 · Cited by 384 · see citing works

3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease

Brouillet, E., Jacquard, C., Bizat, N., & Blum, D. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03515.x · Cited by 361 · see citing works

Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease

Kim, J., Moody, J. P., Edgerly, C. K., Bordiuk, O. L., Cormier, K., Smith, K., Beal, M. F., & Ferrante, R. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq306 · Cited by 356 · see citing works

Choosing an animal model for the study of Huntington's disease

Pouladi, M. A., Morton, A. J., & Hayden, M. R. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3570 · Cited by 350 · see citing works

Meningeal cells can communicate with astrocytes by calcium signaling

Grafstein, B., Liu, S., Cotrina, M. L., Goldman, S. A., & Nedergaard, M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1 · Cited by 50 · see citing works

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

Höglinger, G. U., Féger, J., Prigent, A., Michel, P. P., Parain, K., Champy, P., Ruberg, M., Oertel, W. H., & Hirsch, É. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01533.x · Cited by 331 · see citing works

The development of mitochondrial medicine.

Luft, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8731 · Cited by 302 · see citing works

Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate

Beal, M. F., Brouillet, E., Jenkins, B. G., Henshaw, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03633.x · Cited by 297 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

Mitochondria in Huntington's disease

Damiano, M. G., Galvan, L., Déglon, N., & Brouillet, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.012 · Cited by 282 · see citing works

Antioxidants as treatment for neurodegenerative disorders

Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 253 · see citing works

The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases

Gururaj Joshi, A., & Johnson, J. A. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803252023 · Cited by 246 · see citing works

Bioenergetics and glutamate excitotoxicity

Greene, J. G., & Greenamyre, J. T. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00006-8 · Cited by 246 · see citing works

1 H NMR spectroscopy studies of Huntington's disease

Jenkins, B. G., Rosas, H. D., Chen, Y. I., Makabe, T., Myers, R. H., MacDonald, M. E., Rosen, B. R., Beal, M. F., & Koroshetz, W. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1357 · Cited by 241 · see citing works

Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly

Kumar, A., & Ratan, R. R. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160205 · Cited by 236 · see citing works

Impaired PGC-1α function in muscle in Huntington's disease

Chaturvedi, R. K., Adhihetty, P. J., Shukla, S., Hennessy, T., Calingasan, N. Y., Yang, L., Starkov, A. A., Kiaei, M., Cannella, M., Sassone, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp243 · Cited by 237 · see citing works

The pattern and mechanism of mitochondrial transport in axons

Hollenbeck, P. J. (1996) · Frontiers in bioscience · doi:10.2741/a118 · Cited by 219 · see citing works

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats

Andreassen, O. A., & Jørgensen, H. A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00064-7 · Cited by 211 · see citing works

Atlas of the aging mouse brain reveals white matter as vulnerable foci

Hahn, O., Foltz, A. G., Atkins, M., Kedir, B., Moran-Losada, P., Guldner, I. H., Munson, C., Kern, F., Pálovics, R., Lu, N., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.027 · Cited by 213 · see citing works

3-Nitropropionic acid animal model and Huntington' s disease

Borlongan, C. V., Koutouzis, T. K., & Sanberg, P. R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00027-9 · Cited by 194 · see citing works

Coenzyme Q₁₀ and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate

Beal, M. F., Henshaw, D. R., Jenkins, B. G., Rosen, B. R., & Schulz, J. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360613 · Cited by 189 · see citing works

Delayed-onset progressive movement disorders after static brain lesions

Scott, B. L., & Jankovic, J. J. (1996) · Neurology · doi:10.1212/wnl.46.1.68 · Cited by 189 · see citing works

Neuroprotective effects of creatine

Beal, M. F. (2011) · Amino Acids · doi:10.1007/s00726-011-0851-0 · Cited by 191 · see citing works

The etiology of Parkinson's disease with emphasis on the MPTP story

Langston, J. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.153s · Cited by 180 · see citing works

Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases

Adhihetty, P. J., & Beal, M. F. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8053-y · Cited by 184 · see citing works

Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice

Jenkins, B. G., Klivènyi, P., Küstermann, E., Andreassen, O. A., Ferrante, R. J., Rosen, B. R., & Beal, M. F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742108.x · Cited by 170 · see citing works

Evidence of Oxidant Damage in Huntington's Disease: Translational Strategies Using Antioxidants

Stack, E. C., Matson, W. R., & Ferrante, R. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.008 · Cited by 167 · see citing works

Gait dynamics in mouse models of Parkinson's disease and Huntington's disease

Amende, I., Kale, A., McCue, S., Glazier, S., Morgan, J. P., & Hampton, T. (2005) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-2-20 · Cited by 167 · see citing works

Modulation of gene expression rather than monoamine oxidase inhibition

Tatton, W. G. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.171s · Cited by 167 · see citing works

Increased Hypoxic Tolerance by Chemical Inhibition of Oxidative Phosphorylation: “Chemical Preconditioning”

Riepe, M. W., Esclaire, F., Kasischke, K. A., Schreiber, S., Nakase, H., Kempski, O. S., Ludolph, A. C., Dirnagl, U., & Hugon, J. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199703000-00002 · Cited by 161 · see citing works

Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington’s disease

Bhatt, R., Singh, D., Prakash, A. K., & Mishra, N. (2014) · Drug Delivery · doi:10.3109/10717544.2014.880860 · Cited by 160 · see citing works

Aberrant Rab11-Dependent Trafficking of the Neuronal Glutamate Transporter EAAC1 Causes Oxidative Stress and Cell Death in Huntington's Disease

Li, X., Valencia, A., Sapp, E., Masso, N., Alexander, J. S., Reeves, P., Kegel, K. B., D, N. A. M., & DiFiglia, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5865-09.2010 · Cited by 159 · see citing works

Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid

Guyot, M., Hantraye, P., Dolan, R., Palfi, S., Mazière, M., & Brouillet, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00602-1 · Cited by 158 · see citing works

Mouse models of Huntington's disease and methodological considerations for therapeutic trials

Ferrante, R. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.04.001 · Cited by 150 · see citing works

Cardioprotection by metabolic shut-down and gradual wake-up

Burwell, L. S., Nadtochiy, S. M., & Brookes, P. S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.026 · Cited by 146 · see citing works

INVOLVEMENT OF OXIDATIVE STRESS IN 3-NITROPROPIONIC ACID NEUROTOXICITY

Schulz, J. B., Henshaw, D. R., MacGarvey, U. M., & Beal, M. F. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00122-0 · Cited by 145 · see citing works

Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease

Lastres‐Becker, I., de Miguel, R., PETROCELLIS, L. D., Makriyannis, A., Marzo, V. D., & Fernández‐Ruíz, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01595.x · Cited by 143 · see citing works

Rapid ATP Loss Caused by Methamphetamine in the Mouse Striatum: Relationship Between Energy Impairment and Dopaminergic Neurotoxicity

Chan, P., Monte, D. A. D., Luo, J. J., DeLanney, L. E., Irwin, I., & Langston, J. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062484.x · Cited by 141 · see citing works

Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases

Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 139 · see citing works

Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation

Chaturvedi, R. K., Calingasan, N. Y., Yang, L., Hennessey, T., Johri, A., & Beal, M. F. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq229 · Cited by 135 · see citing works

Topical Review: Glutamate in Neurologic Diseases

Bittigau, P., & Ikonomidou, C. (1997) · Journal of Child Neurology · doi:10.1177/088307389701200802 · Cited by 131 · see citing works

Fatigue in patients with Parkinson's disease

Karlsen, K., Larsen, J. O., Tandberg, E., & J�rgensen, K. (1999) · Movement Disorders · doi:10.1002/1531-8257(199903)14:2 · Cited by 235 · see citing works

Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease

Acevedo‐Torres, K., Berríos, L., Rosario, N., Dufault, V. M., Skatchkov, S. N., Eaton, M. J., Torres‐Ramos, C. A., & Ayala‐Torres, S. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.004 · Cited by 126 · see citing works

S-Nitrosylation of Dynamin-Related Protein 1 Mediates Mutant Huntingtin-Induced Mitochondrial Fragmentation and Neuronal Injury in Huntington's Disease

Haun, F., Nakamura, T., Shiu, A. D., Cho, D.-H., Tsunemi, T., Holland, E. A., Spada, A. R. L., & Lipton, S. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4928 · Cited by 125 · see citing works

In Vivo Calpain/Caspase Cross-talk during 3-Nitropropionic Acid-induced Striatal Degeneration

Bizat, N., Hermel, J., Humbert, S., Jacquard, C., Créminon, C., Escartin, C., Saudou, F., Krajewski, S., Hantraye, P., & Brouillet, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305057200 · Cited by 125 · see citing works

Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction

Goswami, A., Dikshit, P., Mishra, A., Mulherkar, S. A., Nukina, N., & Jana, N. R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.136 · Cited by 124 · see citing works

Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid

Brusque, A. M., Rosa, R. B., Schuck, P. F., Dalcin, K. B., Ribeiro, C. A. J., Silva, C. G., Wannmacher, C. M. D., Dutra‐Filho, C. S., Wyse, Â. T. D. S., Briones, P., et al. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00130-9 · Cited by 123 · see citing works

Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease

Borlongan, C. V., Koutouzis, T. K., Freeman, T. B., Cahill, D. W., & Sanberg, P. R. (1995) · Brain Research · doi:10.1016/0006-8993(95)00901-2 · Cited by 123 · see citing works

Systemic 3-nitropropionic acid: Behavioral deficits and striatal damage in adult rats

Borlongan, C. V., Koutouzis, T. K., Randall, T. S., Freeman, T. B., Cahill, D. W., & Sanberg, P. R. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00242-s · Cited by 122 · see citing works

Effect of Exogenous and Endogenous Antioxidants on 3‐Nitropionic Acid‐Inducedin vivo Oxidative Stress and Striatal Lesions

Fontaine, M. A. L., Geddes, J. W., Banks, A., & Butterfield, D. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751709.x · Cited by 118 · see citing works

Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders

Meldrum, B. S. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90014-q · Cited by 118 · see citing works

Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3‐nitropropionic acid

Rosenstock, T. R., Carvalho, A. C. P., Jurkiewicz, A., Frussa‐Filho, R., & Smaili, S. S. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02250.x · Cited by 117 · see citing works

Dopamine Modulates the Susceptibility of Striatal Neurons to 3-Nitropropionic Acid in the Rat Model of Huntington’s Disease

Reynolds, D. S., Carter, R. J., & Morton, A. J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10116.1998 · Cited by 117 · see citing works

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease

Lastres‐Becker, I., Hansen, H. H., Berrendero, F., de Miguel, R., Pérez‐Rosado, A., Manzanares, J., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Synapse · doi:10.1002/syn.10054 · Cited by 116 · see citing works

Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1 H NMR spectroscopy

Tkáč, I., Dubinsky, J. M., Keene, C. D., Rolf Gruetter, A., & Low, W. C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04323.x · Cited by 112 · see citing works

Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies

Ouary, S., Bizat, N., Altairac, S., Ménétrat, H., Mittoux, V., Condé, F., Hantraye, P., & Brouillet, E. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00020-8 · Cited by 111 · see citing works

Chapter 21 Glutamate toxicity in chronic neurodegenerative disease

Lancelot, E., & Beal, M. F. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)60446-x · Cited by 110 · see citing works

Methylmalonate toxicity in primary neuronal cultures

McLaughlin, B., NELSON, D. S., Silver, I. A., Erecińska, M., & Chesselet, M. ‐. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00594-0 · Cited by 107 · see citing works

Expression of Concern: Role of LOX/COX pathways in 3‐nitropropionic acid‐induced Huntington's Disease‐like symptoms in rats: protective effect of licofelone

Kumar, P., Kalonia, H., & Kumar, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01418.x · Cited by 108 · see citing works

Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism

Jhala, S. S., & Hazell, A. S. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.11.019 · Cited by 107 · see citing works

The Mitochondrial Toxin 3-Nitropropionic Acid Induces Striatal Neurodegeneration via a c-Jun N-Terminal Kinase/c-Jun Module

García, M., Vanhoutte, P., Pagès, C., Besson, M., Brouillet, E., & Caboche, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02174.2002 · Cited by 102 · see citing works

Protective actions of l-carnitine and acetyl-l-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors

Virmani, A., Biselli, R., Spadoni, A., Rossi, S., Corsico, N., Calvani, M., Fattorossi, A., Simone, C. D., & Arrigoni‐Martelli, E. (1995) · Pharmacological Research · doi:10.1016/s1043-6618(05)80044-1 · Cited by 101 · see citing works

Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA)

Ross, C. A., Margolis, R. L., Rosenblatt, A., Ranen, N. G., Bêcher, M. W., & Aylward, E. (1997) · Medicine · doi:10.1097/00005792-199709000-00001 · Cited by 101 · see citing works

Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid)

He, F., Zhang, S., Qian, F., & Zhang, C. (1995) · Neurology · doi:10.1212/wnl.45.12.2178 · Cited by 100 · see citing works

The role of oxidative stress in Huntington’s disease: Are antioxidants good therapeutic candidates?

Gil-Mohapel, J., Brocardo, P., & Christie, B. (2014) · Current Drug Targets · doi:10.2174/1389450115666140115113734 · Cited by 101 · see citing works

Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study.

Harms, L., Meierkord, H., Timm, G., Pfeiffer, L., & Ludolph, A. C. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.27 · Cited by 99 · see citing works

NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals

Kirschner, P. B., Jenkins, B. G., Schulz, J. B., Finkelstein, S. P., Matthews, R. T., Rosen, B. R., & Beal, M. F. (1996) · Brain Research · doi:10.1016/0006-8993(95)01513-2 · Cited by 99 · see citing works

Effects of α-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionate

Nakao, N., & Brundin, P. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00223-0 · Cited by 94 · see citing works

Malonate produces striatal lesions by indirect NMDA receptor activation

Henshaw, R., Jenkins, B. G., Schulz, J. B., Ferrante, R. J., Kowall, N. W., Rosen, B. R., & Beal, M. F. (1994) · Brain Research · doi:10.1016/0006-8993(94)91412-5 · Cited by 92 · see citing works

Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production

Wajner, M., & Coelho, J. C. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005359416197 · Cited by 91 · see citing works

Kaempferol protects against rat striatal degeneration induced by 3‐nitropropionic acid

Lagoa, R., López‐Sánchez, C., Samhan-Arias, A. K., Gañán, C., García‐Martínez, V., & Gutiérrez‐Merino, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06331.x · Cited by 91 · see citing works

Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

Lastres‐Becker, I., Fezza, F., Cebeira, M., Bisogno, T., Ramos, J. A., Milone, A., Fernández‐Ruíz, J., & Marzo, V. D. (2001) · Neuroreport · doi:10.1097/00001756-200107200-00017 · Cited by 89 · see citing works

3-Hydroxykynurenine Toxicity on the Rat Striatum In Vivo

Nakagami, Y., Saitō, H., & Katsuki, H. (1996) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.71.183 · Cited by 88 · see citing works

Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology

Turski, L., & Turski, W. A. (1993) · Cellular and Molecular Life Sciences · doi:10.1007/bf01929915 · Cited by 88 · see citing works

Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease

Gupta, S., & Sharma, B. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.03.022 · Cited by 86 · see citing works

Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation

Hellweg, R., Arnim, C. A. F. V., Büchner, M., Huber, R., & Riepe, M. W. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00127-4 · Cited by 86 · see citing works

3-Nitropropionic Acid (3-NPA), a Potent Antimycobacterial Agent from Endophytic Fungi: Is 3-NPA in Some Plants Produced by Endophytes?

Chomcheon, P., Wiyakrutta, S., Sriubolmas, N., Ngamrojanavanich, N., Isarangkul, D., & Kittakoop, P. (2005) · Journal of Natural Products · doi:10.1021/np050036a · Cited by 85 · see citing works

Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition

Maciel, E. N., Kowaltowski, A. J., Schwalm, F. D., Rodrigues, J. M., Souza, D. O., Vercesi, A. E., Wajner, M., & Castilho, R. F. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02565.x · Cited by 82 · see citing works

Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington’s disease model in rats

Suganya, S., & Sumathi, T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9929-4 · Cited by 84 · see citing works

Corticostriatopallidal Neuroprotection by Adenovirus-Mediated Ciliary Neurotrophic Factor Gene Transfer in a Rat Model of Progressive Striatal Degeneration

Mittoux, V., Ouary, S., Monville, C., Lisovoski, F., Poyot, T., Condé, F., Escartin, C., Robichon, R., Brouillet, E., Peschanski, M., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04478.2002 · Cited by 84 · see citing works

Non-Invasive Neurochemical Analysis of Focal Excitotoxic Lesions in Models of Neurodegenerative Illness Using Spectroscopic Imaging

Jenkins, B. G., Brouillet, E., Chen, Y. I., Storey, E., Schulz, J. B., Kirschner, P. B., Beal, M. F., & Rosen, B. R. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199605000-00011 · Cited by 84 · see citing works

3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease

Fontaine, M. A. L., Geddes, J. W., Banks, A., & Butterfield, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01948-x · Cited by 84 · see citing works

A review of creatine supplementation in age-related diseases: more than a supplement for athletes

Smith, R. N., Agharkar, A. S., & Gonzales, E. B. (2014) · F1000Research · doi:10.12688/f1000research.5218.1 · Cited by 82 · see citing works

Astrocyte-Specific Overexpression of Nrf2 Protects Striatal Neurons from Mitochondrial Complex II Inhibition

Calkins, M. J., Vargas, M. R., Johnson, D. A., & Johnson, J. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq072 · Cited by 82 · see citing works

Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice

Stack, E. C., Dedeoglu, A., Smith, K. M., Cormier, K., Kubilus, J. K., Bogdanov, M. B., Matson, W. R., Yang, L., Jenkins, B. G., Luthi‐Carter, R., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4318-07.2007 · Cited by 80 · see citing works

Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype

Tadros, M. G., Khalifa, A. E., Abdel‐Naim, A. B., & Arafa, H. M. M. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.10.018 · Cited by 79 · see citing works

Calcium and cell death signaling in neurodegeneration and aging

Smaili, S. S., Hirata, H., Ureshino, R. P., Monteforte, P. T., Morales, A. P., Muler, M. L., Terashima, J. Y., Oseki, K., Rosenstock, T. R., Lopes, G. S., et al. (2009) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652009000300011 · Cited by 79 · see citing works

Recent developments in the molecular genetics of mitochondrial disorders

Graeber, M. B., & Müller, U. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00295-5 · Cited by 79 · see citing works

Age dependence of striatal neuronal death caused by mitochondrial dysfunction

Bossi, S. R., Simpson, J. R., & Isacson, O. (1993) · Neuroreport · doi:10.1097/00001756-199301000-00019 · Cited by 80 · see citing works

3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease

Brouillet, E., Jacquard, C., Bizat, N., & Blum, D. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03515.x · Cited by 361 · see citing works

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026 · see citing works

Mice Transgenic for the Huntington's Disease Mutation Are Resistant to Chronic 3‐Nitropropionic Acid‐Induced Striatal Toxicity

Hickey, M. A., & Morton, A. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752163.x · Cited by 53 · see citing works

3-Nitropropionic Acid and Other Metabolic Toxin Lesions of the Striatum

Borlongan, C. V., & Sanberg, P. R. (2011) · Neuromethods · doi:10.1007/978-1-61779-301-1_5